Poniard Pharmaceuticals, Inc. Stock OTC Markets

Stocks

PARDP

US7324492021

Pharmaceuticals

OTC Markets Traded
Delayed 5-day change 1st Jan Change
- USD -.--% Intraday chart for Poniard Pharmaceuticals, Inc. -.--% -

Valuation: Poniard Pharmaceuticals, Inc.

Market Cap 3.19M 2.81M 2.66M 2.41M 4.52M 307M 4.55M 31.8M 12.28M 156M 11.99M 11.73M 503M P/E 2009
-1.4x
P/E 2010 -0.79x
Enterprise Value 437K 385K 364K 330K 620K 41.98M 623K 4.36M 1.68M 21.42M 1.64M 1.61M 68.84M EV / Sales 2009
-
EV / Sales 2010 -
Free-Float
2.5%
Yield 2009 *
-
Yield 2010 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 149
-0.80%+14.07%+705.55%+96.75% 78.76B
-4.54%-5.75%+33.40%-9.86% 75.12B
+0.21%+0.87%-8.39%-27.31% 61.14B
-0.89%+0.19%+7.92%+172.79% 46.07B
+2.49%-0.14%-8.95%+33.71% 47.57B
+0.48%+4.39%+66.48%-11.30% 33.79B
+0.75%+0.14%+50.93%+112.97% 25.3B
-0.05%-6.74%+2.72%+151.37% 21.34B
+0.73%-0.95%+61.19%+97.04% 15.36B
Average -0.06%+0.91%+101.21%+68.46% 44.94B
Weighted average by Cap. -0.48%+2.03%+153.39%+54.32%

Financials

2009 2010
Net sales - -
Net income -45.72M -40.21M -38.02M -34.48M -64.76M -4.39B -65.14M -455M -176M -2.24B -172M -168M -7.2B -30.05M -26.43M -24.99M -22.67M -42.57M -2.88B -42.82M -299M -116M -1.47B -113M -110M -4.73B
Net Debt -23.12M -20.33M -19.23M -17.44M -32.75M -2.22B -32.94M -230M -88.91M -1.13B -86.8M -84.92M -3.64B -2.76M -2.42M -2.29M -2.08M -3.9M -265M -3.93M -27.44M -10.6M -135M -10.35M -10.12M -434M
Logo Poniard Pharmaceuticals, Inc.
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the development and commercialization of oncology products to impact the lives of people with cancer. It develops picoplatin, a platinum-based chemotherapeutic agent that is in clinical development for multiple cancer indications, treatment combinations and by two routes of administration. The Company has offices in San Francisco, California; and Seattle, Washington in United States.
Employees
-